查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591869

荷爾蒙補充療法市場：按類型、給藥途徑- 2025-2030 年全球預測

Hormone Replacement Therapy Market by Type (Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy), Route of Administration (Oral, Parenteral, Transdermal) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年荷爾蒙補充療法市值為258.3億美元，預計到2024年將達到280.4億美元，複合年成長率為8.66%，到2030年將達到462.1億美元。

荷爾蒙補充療法(HRT) 是治療方法。 HRT 最初是為了緩解女性更年期症狀而開發的，現已擴展到治療內分泌失調，現在包括生物同質和合成選項。 HRT的需求在於緩解荷爾蒙缺乏和失衡引起的症狀，透過解決潮熱、骨質疏鬆、性慾低下和情緒低落等問題，有效提高患者的生活品質。其應用涵蓋醫療機構、診所和家庭，並透過針對更年期患者和荷爾蒙缺乏或性別轉變需求的患者進一步多樣化。壽命的延長、更年期症狀發生率的增加以及荷爾蒙健康意識的增強正在推動市場成長。不斷變化的性別認同和不斷擴大的抗衰老治療應用正在開闢新的途徑。蓬勃發展的個人化醫療領域及其客製化 HRT 的潛力提供了巨大的市場機會。然而，市場面臨監管審查、潛在副作用和高昂治療成本等障礙，這可能會抑制消費者信心和接受度。此外，來自替代療法和自然療法的競爭也帶來了額外的挑戰。創新應著重於提高治療的安全性和有效性，正在進行的植物來源的生物同質激素和用於個人化劑量和監測的數位健康技術的研究尤其有前途。投資消費者教育和宣傳宣傳活動也可以加速接受。市場動態表明，這是一個競爭激烈但蓬勃發展的細分市場，其特徵是技術進步和不斷成長的人口需求。透過對研發的策略性投資以及專注於以患者為中心的綜合解決方案來應對這些複雜性，公司可以成功進入不斷擴大的 HRT 市場。為了獲得持久的客戶忠誠度和市場佔有率成長，重點應放在安全性、有效性和解決更廣泛的患者問題上。

主要市場統計
基準年[2023] 258.3億美元
預測年份 [2024] 280.4億美元
預測年份 [2030] 462.1億美元
複合年成長率（%） 8.66%

市場動態：揭示快速發展的荷爾蒙補充療法市場的關鍵市場洞察

供需的動態交互作用正在改變荷爾蒙補充療法市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 世界人口荷爾蒙失衡加劇
    • 提高對更年期徵兆和治療方案的認知
    • 增加荷爾蒙療法的藥物傳輸系統
  • 市場限制因素
    • 治療費用上漲
  • 市場機會
    • 使用生物同質製劑的荷爾蒙補充療法
    • 創新性新推出荷爾蒙補充療法儀
  • 市場問題
    • 荷爾蒙補充療法對健康的不良影響

波特五力：駕馭荷爾蒙補充療法市場的策略工具

波特的五力框架是了解荷爾蒙補充療法市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解荷爾蒙補充療法市場的外部影響

外部宏觀環境因素在塑造荷爾蒙補充療法市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解荷爾蒙補充療法市場的競爭格局

對荷爾蒙補充療法市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：荷爾蒙補充療法市場供應商的績效評估

FPNV定位矩陣是評估荷爾蒙補充療法市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製荷爾蒙補充療法市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，荷爾蒙補充療法市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界人口中荷爾蒙失衡疾病的增加
      • 提高對更年期徵兆和治療方法的認知
      • 增加荷爾蒙療法的藥物傳輸系統
    • 抑制因素
      • 治療費用高
    • 機會
      • 採用生物同質荷爾蒙補充療法
      • 創新推出荷爾蒙補充療法設備
    • 任務
      • 荷爾蒙補充療法對健康的不良影響
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章荷爾蒙補充療法市場：按類型

  • 介紹
  • 雌激素替代療法
  • 生長激素荷爾蒙補充療法
  • 甲狀腺荷爾蒙補充療法

第7章荷爾蒙補充療法市場：依給藥途徑

  • 介紹
  • 口服
  • 胃腸外的
  • 經皮的

第8章美洲荷爾蒙補充療法市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太荷爾蒙補充療法市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲荷爾蒙補充療法市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Endo International PLC
  • Genentech, Inc.
  • Merck KGaA
  • Mithra Pharmaceuticals
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Transcend Company Inc.
  • Viatris Inc.
  • Wellnexio LLC
Product Code: MRR-43127F7278AB

The Hormone Replacement Therapy Market was valued at USD 25.83 billion in 2023, expected to reach USD 28.04 billion in 2024, and is projected to grow at a CAGR of 8.66%, to USD 46.21 billion by 2030.

Hormone Replacement Therapy (HRT) is a medical treatment aimed at augmenting or replacing hormones that the body no longer produces sufficiently. Initially developed to ease menopausal symptoms in women, HRT has expanded to treat endocrine disorders and now includes bioidentical and synthetic options. The necessity of HRT revolves around mitigating symptoms of hormone deficiency or imbalance, effectively enhancing patients' quality of life by addressing hot flashes, osteoporosis, low libido, and mood swings. Its application spans across healthcare facilities, clinics, and homes, diversified further by targeting both menopausal individuals and those with hormonal deficiencies or gender transition needs. Market growth is fueled by increased longevity, rising menopause occurrences, and greater awareness of hormonal health. Evolving gender identity views and expanding applications in anti-aging treatments are opening fresh avenues. Personalized medicine, a burgeoning aspect with potential for tailored HRT, offers noteworthy market opportunities. However, the market faces obstacles such as regulatory scrutiny, potential side effects, and high therapy costs, possibly impeding consumer trust and uptake. Furthermore, competition from alternative therapies and natural remedies presents additional challenges. Innovations should focus on enhancing therapy safety and efficacy, with ongoing research into plant-based bioidentical hormones and digital health tech for personalized dosing and monitoring being particularly promising. Investment in consumer education and awareness campaigns can also accelerate acceptance. Market dynamics suggest a competitive yet thriving space marked by technological advancements and a growing demographic imperative. By navigating these complexities with strategic investments in R&D and focusing on comprehensive patient-oriented solutions, businesses can successfully tap into the expanding HRT market. The emphasis should be on safety, efficacy, and addressing broader patient concerns to capture enduring customer loyalty and market share expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 25.83 billion
Estimated Year [2024] USD 28.04 billion
Forecast Year [2030] USD 46.21 billion
CAGR (%) 8.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hormone Replacement Therapy Market

The Hormone Replacement Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing hormonal imbalance disorders in global population
    • Growing awareness about menopausal signs and the treatment options
    • Rise in drug delivery systems for hormone therapy
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Introduction of bioidentical hormone replacement therapy
    • Innovative new launches of devices for hormone replacement therapy
  • Market Challenges
    • Adverse health effects of hormone replacement therapy

Porter's Five Forces: A Strategic Tool for Navigating the Hormone Replacement Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hormone Replacement Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hormone Replacement Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hormone Replacement Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hormone Replacement Therapy Market

A detailed market share analysis in the Hormone Replacement Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hormone Replacement Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hormone Replacement Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hormone Replacement Therapy Market

A strategic analysis of the Hormone Replacement Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hormone Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., Bayer AG, Eli Lilly and Company, Endo International PLC, Genentech, Inc., Merck KGaA, Mithra Pharmaceuticals, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Transcend Company Inc., Viatris Inc., and Wellnexio LLC.

Market Segmentation & Coverage

This research report categorizes the Hormone Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy.
  • Based on Route of Administration, market is studied across Oral, Parenteral, and Transdermal.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing hormonal imbalance disorders in global population
      • 5.1.1.2. Growing awareness about menopausal signs and the treatment options
      • 5.1.1.3. Rise in drug delivery systems for hormone therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of bioidentical hormone replacement therapy
      • 5.1.3.2. Innovative new launches of devices for hormone replacement therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse health effects of hormone replacement therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hormone Replacement Therapy Market, by Type

  • 6.1. Introduction
  • 6.2. Estrogen Replacement Therapy
  • 6.3. Growth Hormone Replacement Therapy
  • 6.4. Thyroid Hormone Replacement Therapy

7. Hormone Replacement Therapy Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Parenteral
  • 7.4. Transdermal

8. Americas Hormone Replacement Therapy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Hormone Replacement Therapy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Hormone Replacement Therapy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen Inc.
  • 3. Bayer AG
  • 4. Eli Lilly and Company
  • 5. Endo International PLC
  • 6. Genentech, Inc.
  • 7. Merck KGaA
  • 8. Mithra Pharmaceuticals
  • 9. Novartis AG
  • 10. Novo Nordisk A/S
  • 11. Pfizer Inc.
  • 12. Teva Pharmaceutical Industries Ltd.
  • 13. Transcend Company Inc.
  • 14. Viatris Inc.
  • 15. Wellnexio LLC

LIST OF FIGURES

  • FIGURE 1. HORMONE REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. HORMONE REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HORMONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HORMONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HORMONE REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HORMONE REPLACEMENT THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GROWTH HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THYROID HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. HORMONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. HORMONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023